Science is an endless frontier: Encouraging translational research in pulmonary vascular disease [0.03%]
科学永无止境：促进肺血管疾病转化研究
Jason X-J Yuan,Nicholas W Morrell,S Harikrishnan et al.
Jason X-J Yuan et al.
Author's reply [0.03%]
作者回复
Joanna Pepke-Zaba
Joanna Pepke-Zaba
Regarding "Isolated large vessel pulmonary vasculitis and chronic obstruction of the pulmonary arteries" [0.03%]
关于“孤立性大血管肺血管炎和肺动脉慢性阻塞”
Beuy Joob,Viroj Wiwanitkit
Beuy Joob
The WHO classification of pulmonary hypertension: A case-based imaging compendium [0.03%]
肺动脉高压的WHO分类：基于影像的综合汇编（案例分析）
John J Ryan,Thenappan Thenappan,Nancy Luo et al.
John J Ryan et al.
Pulmonary hypertension (PH) is defined as a resting mean pulmonary artery pressure greater than 25 mmHg. The World Health Organization (WHO) classifies PH into five categories. The WHO nomenclature assumes shared histology and pathophysiolo...
Severe pulmonary hypertension in idiopathic nonspecific interstitial pneumonia [0.03%]
特发性非特异性间质性肺炎合并严重肺动脉高压
Robert W Hallowell,Robert M Reed,Mostafa Fraig et al.
Robert W Hallowell et al.
Pulmonary hypertension (PH) is a common complication of interstitial lung disease (ILD), particularly in idiopathic pulmonary fibrosis (IPF) and ILD associated with connective tissue disease, where the underlying pathology is often a nonspe...
Amy L Firth,Jason X-J Yuan
Amy L Firth
The pulmonary vasculature comprises a complex network of branching arteries and veins all functioning to reoxygenate the blood for circulation around the body. The cell types of the pulmonary artery are able to respond to changes in oxygen ...
Pulmonary acceleration time to optimize the timing of lung transplant in cystic fibrosis [0.03%]
肺加速时间在囊性纤维化患者中优化肺移植时机的作用
Thibaud Damy,Pierre-Régis Burgel,Jean-Louis Pepin et al.
Thibaud Damy et al.
Pulmonary hypertension (PH) may affect survival in cystic fibrosis (CF) and can be assessed on echocardiographic measurement of the pulmonary acceleration time (PAT). The study aimed at evaluating PAT as a tool to optimize timing of lung tr...
Estimation of endothelin-mediated vasoconstriction in acute pulmonary thromboembolism [0.03%]
急性肺血栓栓塞时内皮素介导的血管收缩作用的评估
John Y C Tsang,Wayne J E Lamm
John Y C Tsang
We aimed to investigate the role of endothelin-mediated vasoconstriction following acute pulmonary thromboembolism (APTE). Thirteen anesthetized piglets (~25 kg) were ventilated with 0 PEEP. Cardiac output (Qt) and wedge pressure (Pw) were ...
Inhaled epoprostenol therapy for pulmonary hypertension: Improves oxygenation index more consistently in neonates than in older children [0.03%]
吸入依普利松治疗肺动脉高压：与年长儿童相比可更有效地改善新生儿的氧合指数
Anna T Brown,Jennifer V Gillespie,Franscesca Miquel-Verges et al.
Anna T Brown et al.
The purpose of this study was to determine the efficacy of inhaled epoprostenol for treatment of acute pulmonary hypertension (PH) in pediatric patients and to formulate a plan for a prospective, randomized study of pulmonary vasodilator th...
Characterization of altered patterns of endothelial progenitor cells in sickle cell disease related pulmonary arterial hypertension [0.03%]
镰状细胞病相关肺动脉高压的内皮祖细胞异常表型特征分析
Fatima Anjum,Jason Lazar,Joe Zein et al.
Fatima Anjum et al.
Endothelial dysfunction plays an important role in the pathogenesis of pulmonary arterial hypertension (PAH) in sickle cell disease (SCD). A variety of evidence suggests that circulating endothelial progenitor cells (EPCs) play an integral ...